ADMA Biologics, Inc.
ADMA
$17.02
$0.110.65%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 68.13M | 34.79M | -3.64M | -28.24M | -22.83M |
| Total Depreciation and Amortization | 8.20M | 8.35M | 8.40M | 8.32M | 8.16M |
| Total Amortization of Deferred Charges | 1.44M | 1.91M | 2.37M | 2.60M | 2.39M |
| Total Other Non-Cash Items | 36.94M | 36.53M | 36.29M | 36.24M | 9.83M |
| Change in Net Operating Assets | -28.66M | -8.58M | -22.12M | -10.13M | -13.73M |
| Cash from Operations | 86.05M | 73.01M | 21.30M | 8.80M | -16.18M |
| Capital Expenditure | -6.67M | -6.37M | -5.17M | -4.77M | -7.32M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -566.00K | -524.00K | -225.00K | -210.00K | -- |
| Cash from Investing | -7.23M | -6.89M | -5.40M | -4.98M | -7.32M |
| Total Debt Issued | 135.00M | 135.00M | 135.00M | 135.00M | 0.00 |
| Total Debt Repaid | -188.59M | -158.59M | -158.59M | -158.60M | -24.70K |
| Issuance of Common Stock | 7.06M | 1.99M | 2.13M | 1.10M | 65.92M |
| Repurchase of Common Stock | -4.67M | -3.72M | -3.25M | -1.41M | -3.14M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -15.08M | -15.08M | -15.08M | -15.08M | -100.00 |
| Cash from Financing | -66.27M | -40.39M | -39.79M | -38.99M | 62.75M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 12.55M | 25.73M | -23.88M | -35.17M | 39.25M |
